Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
Dividend Announcement: Cryo-Cell International, Inc. has approved a quarterly cash dividend of $0.25 per share for shareholders of record as of February 14, 2025, with payment expected on February 28, 2025.
Strategic Initiatives Paused: The company has paused its strategic initiatives regarding the potential sale or merger, while continuing to evaluate its dividend policy regularly.
Trade with 70% Backtested Accuracy
Analyst Views on CCEL
About CCEL
About the author

Cryo-Cell International Inc Reports Decrease in Q3 Profit
Earnings Decline: Cryo-Cell International Inc reported a decrease in earnings for the third quarter, with profits falling to $0.75 million ($0.09 per share) from $1.05 million ($0.13 per share) in the same period last year.
Revenue Drop: The company's revenue also declined by 3.0%, totaling $7.83 million compared to $8.07 million in the previous year.

Insider Buying Update for Friday, September 12: CCEL, AROW
Cryo-Cell International Insider Activity: Chairman and Co-CEO David Portnoy purchased 42,900 shares of CCEL at $4.43 each, totaling $189,986, and is currently up 6.1% based on recent trading highs.
Arrow Financial Insider Activity: CFO Penko Krassimir Ivanov bought 5,000 shares of AROW at $29.10 each for a total of $145,499, with previous investments totaling $391,248 at an average of $29.14 per share.






